Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis

Cell Stem Cell

Volumn 10, Issue 5, 2012, Pages 544-555

  Akiyama, Kentaro ^a,b   Chen, Chider ^a   Wang, Dandan ^c   Xu, Xingtian ^a   Qu, Cunye ^a   Yamaza, Takayoshi ^a   Cai, Tao ^d   Chen, Wanjun ^d   Sun, Lingyun ^c   Shi, Songtao ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; FAS ANTIGEN; FAS LIGAND; FIBRILLIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW MESENCHYMAL STEM CELL TRANSPLANTATION; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; GENE OVEREXPRESSION; GRAFT RECIPIENT; HUMAN; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MACROPHAGE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE; TREATMENT RESPONSE; UPREGULATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BONE MARROW CELLS; CHEMOKINE CCL2; COLITIS; DEXTRAN SULFATE; FAS LIGAND PROTEIN; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; SCLERODERMA, SYSTEMIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

MUS;

EID: 84860636948     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2012.03.007     Document Type: Article

References (35)

1. S. Aggarwal, and M.F. Pittenger Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 105 2005 1815 1822
2. P. Alex, N.C. Zachos, T. Nguyen, L. Gonzales, T.E. Chen, L.S. Conklin, M. Centola, and X. Li Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis Inflamm. Bowel Dis. 15 2009 341 352
3. A. Augello, R. Tasso, S.M. Negrini, R. Cancedda, and G. Pennesi Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis Arthritis Rheum. 56 2007 1175 1186
4. P. Batten, P. Sarathchandra, J.W. Antoniw, S.S. Tay, M.W. Lowdell, P.M. Taylor, and M.H. Yacoub Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves Tissue Eng. 12 2006 2263 2273
5. M.E. Bernardo, F. Locatelli, and W.E. Fibbe Mesenchymal stromal cells Ann. N Y Acad. Sci. 1176 2009 101 117
6. M.W. Carr, S.J. Roth, E. Luther, S.S. Rose, and T.A. Springer Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant Proc. Natl. Acad. Sci. USA 91 1994 3652 3656
7. L. Chatenoud, E. Thervet, J. Primo, and J.F. Bach Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice Proc. Natl. Acad. Sci. USA 91 1994 123 127
8. L. Chatenoud, J. Primo, and J.F. Bach CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice J. Immunol. 158 1997 2947 2954
9. X. Chen, M.A. Armstrong, and G. Li Mesenchymal stem cells in immunoregulation Immunol. Cell Biol. 84 2006 413 421
10. H. Choi, R.H. Lee, N. Bazhanov, J.Y. Oh, and D.J. Prockop Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages Blood 118 2011 330 338
11. M.A. González, E. Gonzalez-Rey, L. Rico, D. Büscher, and M. Delgado Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses Gastroenterology 136 2009 978 989
12. M.C. Green, H.O. Sweet, and L.E. Bunker Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton Am. J. Pathol. 82 1976 493 512
13. A.M. Hohlbaum, S. Moe, and A. Marshak-Rothstein Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival J. Exp. Med. 191 2000 1209 1220
14. F. Kleinclauss, S. Perruche, E. Masson, M. de Carvalho Bittencourt, S. Biichle, J.P. Remy-Martin, C. Ferrand, M. Martin, H. Bittard, and J.M. Chalopin Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion Cell Death Differ. 13 2006 41 52
15. K. Le Blanc, I. Rasmusson, B. Sundberg, C. Götherström, M. Hassan, M. Uzunel, O. Ringdén, B. Sundberg, M.E. Bernardo, and M. Remberger Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells Lancet 363 2004 1439 1441
16. J. Liang, H. Zhang, B. Hua, H. Wang, J. Wang, Z. Han, and L. Sun Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis Mult. Scler. 15 2009 644 646
17. J. Mazar, M. Thomas, L. Bezrukov, A. Chanturia, G. Pekkurnaz, S. Yin, S.A. Kuznetsov, P.G. Robey, and J. Zimmerberg Cytotoxicity mediated by the Fas ligand (FasL)-activated apoptotic pathway in stem cells J. Biol. Chem. 284 2009 22022 22028
18. R. Meisel, A. Zibert, M. Laryea, U. Göbel, W. Däubener, and D. Dilloo Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation Blood 103 2004 4619 4621
19. A.J. Nauta, and W.E. Fibbe Immunomodulatory properties of mesenchymal stromal cells Blood 110 2007 3499 3506
20. B. Parekkadan, A.W. Tilles, and M.L. Yarmush Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells Stem Cells 26 2008 1913 1919
21. M.J. Park, H.S. Park, M.L. Cho, H.J. Oh, Y.G. Cho, S.Y. Min, B.H. Chung, J.W. Lee, H.Y. Kim, and S.G. Cho Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis Arthritis Rheum. 63 2011 1668 1680
22. S. Perruche, P. Zhang, Y. Liu, P. Saas, J.A. Bluestone, and W. Chen CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells Nat. Med. 14 2008 528 535
23. S. Pluchino, L. Zanotti, B. Rossi, E. Brambilla, L. Ottoboni, G. Salani, M. Martinello, A. Cattalini, A. Bergami, and R. Furlan Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism Nature 436 2005 266 271
24. D. Polchert, J. Sobinsky, G.W. Douglas, M. Kidd, A. Moadsiri, E. Reina, K. Genrich, S. Mehrotra, S. Setty, B. Smith, and A. Bartholomew IFN-γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease Eur. J. Immunol. 38 2008 1745 1755
25. M. Rafei, P.M. Campeau, A. Aguilar-Mahecha, M. Buchanan, P. Williams, E. Birman, S. Yuan, Y.K. Young, M.N. Boivin, and K. Forner Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner J. Immunol. 182 2009 5994 6002
26. G. Ren, L. Zhang, X. Zhao, G. Xu, Y. Zhang, A.I. Roberts, R.C. Zhao, and Y. Shi Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide Cell Stem Cell 2 2008 141 150
27. G.W. Roddy, J.Y. Oh, R.H. Lee, T.J. Bartosh, J. Ylostalo, K. Coble, R.H. Rosa Jr., and D.J. Prockop Action at a Distance: Systemically Administered Adult Stem/Progenitor Cells (MSCs) Reduce Inflammatory Damage to the Cornea Without Engraftment and Primarily by Secretion of TNF-α stimulated gene/protein 6 Stem Cells 29 2011 1572 1579
28. K. Sato, K. Ozaki, I. Oh, A. Meguro, K. Hatanaka, T. Nagai, K. Muroi, and K. Ozawa Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells Blood 109 2007 228 234
29. L. Sun, K. Akiyama, H. Zhang, T. Yamaza, Y. Hou, S. Zhao, T. Xu, A. Le, and S. Shi Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans Stem Cells 27 2009 1421 1432
30. A. Uccelli, V. Pistoia, and L. Moretta Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol. 28 2007 219 226
31. A. Uccelli, L. Moretta, and V. Pistoia Mesenchymal stem cells in health and disease Nat. Rev. Immunol. 8 2008 726 736
32. L.L. Xu, M.K. Warren, W.L. Rose, W. Gong, and J.M. Wang Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro J. Leukoc. Biol. 60 1996 365 371
33. E. Zappia, S. Casazza, E. Pedemonte, F. Benvenuto, I. Bonanni, E. Gerdoni, D. Giunti, A. Ceravolo, F. Cazzanti, and F. Frassoni Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy Blood 106 2005 1755 1761
34. Y. Zhang, G. Xu, L. Zhang, A.I. Roberts, and Y. Shi Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-gamma J. Immunol. 181 2008 190 196
35. Q. Zhang, S. Shi, Y. Liu, J. Uyanne, Y. Shi, S. Shi, and A.D. Le Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis J. Immunol. 183 2010 7787 7798